Virbac jumps on Stifel upgrade to 'buy', cheap stock price

Virbac SA

17/03/2025 09:27

** Shares in Virbac VIRB.PA rise more than 10% after Stifel upgrades the French producer of drugs and food for animals to "buy" from "hold" citing attractive risk/reward

** Virbac's results on Thursday were "reassuring", while its guidance and growth targets are "reasonable and credible", Stifel says

** "Slowdown in profit growth is likely to continue in H1-25 due to an unfavourable base effect. However, profit growth could accelerate again in the second half of the year," it says

** Virbac's low valuation also justifies Monday's jump, a Midcap Partners analyst says

** The Paris-listed stock is up 3% YTD to 327 euros, after falling on Friday to its lowest levels since December 2023

($1 = 0.9191 euros)

 (Reporting by Alessandro Parodi)

 ((alessandro.parodi@thomsonreuters.com))